{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T07:58:24Z","timestamp":1777103904971,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ncl.2020.01.006","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T08:56:41Z","timestamp":1583744201000},"page":"349-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Medical and Surgical Treatments of Tourette Syndrome"],"prefix":"10.1016","volume":"38","author":[{"given":"Joohi","family":"Jimenez-Shahed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ncl.2020.01.006_bib1","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1212\/CON.0000000000000752","article-title":"Tics and Tourette syndrome","volume":"25","author":"Singer","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"issue":"8","key":"10.1016\/j.ncl.2020.01.006_bib2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/08830738060210081001","article-title":"Tourette syndrome: the self under siege","volume":"21","author":"Leckman","year":"2006","journal-title":"J\u00a0Child Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2020.01.006_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.beth.2013.09.002","article-title":"The premonitory urge to tic: measurement, characteristics, and correlates in older adolescents and adults","volume":"45","author":"Reese","year":"2014","journal-title":"Behav Ther"},{"issue":"11","key":"10.1016\/j.ncl.2020.01.006_bib4","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/mds.21577","article-title":"Tic suppression in the treatment of Tourette's syndrome with exposure therapy: the rebound phenomenon reconsidered","volume":"22","author":"Verdellen","year":"2007","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.ncl.2020.01.006_bib5","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1469-8749.2008.03168.x","article-title":"Understanding disability in Tourette syndrome","volume":"51","author":"Pringsheim","year":"2009","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2020.01.006_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/mds.26089","article-title":"Population prevalence of Tourette syndrome: a systematic review and meta-analysis","volume":"30","author":"Scharf","year":"2015","journal-title":"Mov Disord"},{"issue":"16","key":"10.1016\/j.ncl.2020.01.006_bib7","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJMra010032","article-title":"Tourette's syndrome","volume":"345","author":"Jankovic","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ncl.2020.01.006_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archpedi.160.1.65","article-title":"Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome","volume":"160","author":"Bloch","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"6","key":"10.1016\/j.ncl.2020.01.006_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jpsychores.2009.09.002","article-title":"Clinical course of Tourette syndrome","volume":"67","author":"Bloch","year":"2009","journal-title":"J\u00a0Psychosom Res"},{"issue":"Suppl 1","key":"10.1016\/j.ncl.2020.01.006_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00787-007-1003-7","article-title":"Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome","volume":"16","author":"Freeman","year":"2007","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"1 Pt 1","key":"10.1016\/j.ncl.2020.01.006_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1542\/peds.102.1.14","article-title":"Course of tic severity in Tourette syndrome: the first two decades","volume":"102","author":"Leckman","year":"1998","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ncl.2020.01.006_bib12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","article-title":"The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity","volume":"28","author":"Leckman","year":"1989","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"10.1016\/j.ncl.2020.01.006_bib13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1037\/1040-3590.17.4.486","article-title":"Reliability and validity of the Yale Global Tic Severity Scale","volume":"17","author":"Storch","year":"2005","journal-title":"Psychol Assess"},{"issue":"6","key":"10.1016\/j.ncl.2020.01.006_bib14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1089\/cap.2010.0149","article-title":"Defining treatment response in pediatric tic disorders: a signal detection analysis of the Yale Global Tic Severity Scale","volume":"21","author":"Storch","year":"2011","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"4","key":"10.1016\/j.ncl.2020.01.006_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00787-011-0163-7","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment","volume":"20","author":"Roessner","year":"2011","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"19","key":"10.1016\/j.ncl.2020.01.006_bib16","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1212\/WNL.0000000000007466","article-title":"Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders","volume":"92","author":"Pringsheim","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2020.01.006_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/NDT.S12990","article-title":"Update on the role of antipsychotics in the treatment of Tourette syndrome","volume":"8","author":"Huys","year":"2012","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.ncl.2020.01.006_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/B978-0-12-411546-0.00010-X","article-title":"Clinical pharmacology of dopamine-modulating agents in Tourette's syndrome","volume":"112","author":"Mogwitz","year":"2013","journal-title":"Int Rev Neurobiol"},{"issue":"3","key":"10.1016\/j.ncl.2020.01.006_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/070674371205700302","article-title":"Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy","volume":"57","author":"Pringsheim","year":"2012","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.ncl.2020.01.006_bib20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.5334\/tohm.287","article-title":"Deutetrabenazine in tics associated with Tourette syndrome","volume":"6","author":"Jankovic","year":"2016","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"1","key":"10.1016\/j.ncl.2020.01.006_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/WNF.0000000000000017","article-title":"A\u00a0D1 receptor antagonist, ecopipam, for treatment of tics in Tourette syndrome","volume":"37","author":"Gilbert","year":"2014","journal-title":"Clin Neuropharmacol"},{"issue":"8","key":"10.1016\/j.ncl.2020.01.006_bib22","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/mds.27457","article-title":"Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: a randomized, placebo-controlled crossover study","volume":"33","author":"Gilbert","year":"2018","journal-title":"Mov Disord"},{"issue":"12","key":"10.1016\/j.ncl.2020.01.006_bib23","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s40263-018-0580-y","article-title":"VMAT2 inhibitors in neuropsychiatric disorders","volume":"32","author":"Tarakad","year":"2018","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.ncl.2020.01.006_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejpn.2013.01.005","article-title":"Tourette syndrome and comorbid ADHD: current pharmacological treatment options","volume":"17","author":"Rizzo","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2020.01.006_bib25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.58.4.527","article-title":"Treatment of ADHD in children with tics: a randomized controlled trial","volume":"58","author":"Tourette's Syndrome Study","year":"2002","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2020.01.006_bib26","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.neubiorev.2012.09.008","article-title":"Systematic review: pharmacological treatment of tic disorders\u2013\u2013efficacy of antipsychotic and alpha-2 adrenergic agonist agents","volume":"37","author":"Weisman","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.1016\/j.ncl.2020.01.006_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jnnp.2009.185348","article-title":"A\u00a0randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome","volume":"81","author":"Jankovic","year":"2010","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.ncl.2020.01.006_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/WNF.0b013e3181c295c1","article-title":"Topiramate in treatment of Tourette syndrome","volume":"33","author":"Kuo","year":"2010","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"10.1016\/j.ncl.2020.01.006_bib29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum neurotoxins: biology, pharmacology, and toxicology","volume":"69","author":"Pirazzini","year":"2017","journal-title":"Pharmacol Rev"},{"issue":"5","key":"10.1016\/j.ncl.2020.01.006_bib30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1212\/WNL.56.5.605","article-title":"Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial","volume":"56","author":"Marras","year":"2001","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2020.01.006_bib31","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s10072-003-0201-4","article-title":"Treatment of phonic tics in patients with Tourette's syndrome using botulinum toxin type A","volume":"24","author":"Porta","year":"2004","journal-title":"Neurol Sci"},{"key":"10.1016\/j.ncl.2020.01.006_bib32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jpsychires.2013.12.009","article-title":"A\u00a0meta-analysis of behavior therapy for Tourette syndrome","volume":"50","author":"McGuire","year":"2014","journal-title":"J\u00a0Psychiatr Res"},{"issue":"1","key":"10.1016\/j.ncl.2020.01.006_bib33","first-page":"7","article-title":"The effectiveness of habit reversal therapy in the treatment of Tourette syndrome and other chronic tic disorders: a systematic review","volume":"28","author":"Dutta","year":"2013","journal-title":"Funct Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2020.01.006_bib34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cbpra.2017.01.003","article-title":"Tic treatment goes tech: a review of TicHelper.com","volume":"24","author":"Conelea","year":"2017","journal-title":"Cogn Behav Pract"},{"key":"10.1016\/j.ncl.2020.01.006_bib35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fpsyt.2016.00119","article-title":"The ONLINE-TICS study protocol: a randomized observer-blind clinical trial to demonstrate the efficacy and safety of internet-delivered behavioral treatment for adults with chronic tic disorders","volume":"7","author":"Jakubovski","year":"2016","journal-title":"Front Psychiatry"},{"issue":"6","key":"10.1016\/j.ncl.2020.01.006_bib36","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1600-0447.1998.tb10127.x","article-title":"Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome","volume":"98","author":"Muller-Vahl","year":"1998","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"10.1016\/j.ncl.2020.01.006_bib37","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1176\/appi.neuropsych.16110310","article-title":"Preliminary evidence on cannabis effectiveness and tolerability for adults with Tourette syndrome","volume":"29","author":"Abi-Jaoude","year":"2017","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.ncl.2020.01.006_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.parkreldis.2018.10.004","article-title":"Single center experience with medical cannabis in Gilles de la Tourette syndrome","volume":"61","author":"Thaler","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2020.01.006_bib39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3389\/fphar.2016.00309","article-title":"Current therapeutic cannabis controversies and clinical trial design issues","volume":"7","author":"Russo","year":"2016","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.ncl.2020.01.006_bib40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1155\/2013\/294264","article-title":"Treatment of Tourette syndrome with cannabinoids","volume":"27","author":"Muller-Vahl","year":"2013","journal-title":"Behav Neurol"},{"issue":"45\u201346","key":"10.1016\/j.ncl.2020.01.006_bib41","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4414\/smw.2004.10802","article-title":"Cannabis and risk of psychosis","volume":"134","author":"Drewe","year":"2004","journal-title":"Swiss Med Wkly"},{"issue":"2","key":"10.1016\/j.ncl.2020.01.006_bib42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/pch\/pxx017","article-title":"Cannabis and Canada's children and youth","volume":"22","author":"Grant","year":"2017","journal-title":"Paediatr Child Health"},{"issue":"2","key":"10.1016\/j.ncl.2020.01.006_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2002-25028","article-title":"Treatment of Tourette's syndrome with delta 9-tetrahydrocannabinol (THC): a randomized crossover trial","volume":"35","author":"Muller-Vahl","year":"2002","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"10.1016\/j.ncl.2020.01.006_bib44","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4088\/JCP.v64n0417","article-title":"Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial","volume":"64","author":"Muller-Vahl","year":"2003","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.ncl.2020.01.006_bib45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neubiorev.2018.03.008","article-title":"Residual effects of cannabis use in adolescent and adult brain\u2013\u2013a meta-analysis of fMRI studies","volume":"88","author":"Blest-Hopley","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"10.1016\/j.ncl.2020.01.006_bib46","first-page":"1297","article-title":"Adolescent cannabinoid exposure induces a persistent sub-cortical hyper-dopaminergic state and associated molecular adaptations in the prefrontal cortex","volume":"27","author":"Renard","year":"2017","journal-title":"Cereb Cortex"},{"issue":"5","key":"10.1016\/j.ncl.2020.01.006_bib47","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bbalip.2018.02.001","article-title":"Delta(9)-Tetrahydrocannabinol changes the brain lipidome and transcriptome differentially in the adolescent and the adult","volume":"1863","author":"Leishman","year":"2018","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"1","key":"10.1016\/j.ncl.2020.01.006_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mds.10649","article-title":"Surgery in Tourette syndrome","volume":"19","author":"Temel","year":"2004","journal-title":"Mov Disord"},{"issue":"9154","key":"10.1016\/j.ncl.2020.01.006_bib49","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0140-6736(98)05964-9","article-title":"Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus","volume":"353","author":"Vandewalle","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ncl.2020.01.006_bib50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000337776","article-title":"Deep brain stimulation for Tourette syndrome: target selection","volume":"90","author":"Viswanathan","year":"2012","journal-title":"Stereotact Funct Neurosurg"},{"issue":"6","key":"10.1016\/j.ncl.2020.01.006_bib51","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S1474-4422(15)00043-5","article-title":"Design challenges for stimulation trials of Tourette's syndrome","volume":"14","author":"Jimenez-Shahed","year":"2015","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2020.01.006_bib52","first-page":"1004","article-title":"Prospective randomized double-blind trial of bilateral thalamic deep brain stimulation in adults with Tourette syndrome","volume":"107","author":"Maciunas","year":"2007","journal-title":"J\u00a0Neurosurg"},{"issue":"7","key":"10.1016\/j.ncl.2020.01.006_bib53","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/archneur.65.7.952","article-title":"Internal pallidal and thalamic stimulation in patients with Tourette syndrome","volume":"65","author":"Welter","year":"2008","journal-title":"Arch Neurol"},{"issue":"Pt 3","key":"10.1016\/j.ncl.2020.01.006_bib54","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/brain\/awq380","article-title":"Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome","volume":"134","author":"Ackermans","year":"2011","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ncl.2020.01.006_bib55","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1474-4422(15)00008-3","article-title":"Bilateral globus pallidus stimulation for severe Tourette's syndrome: a double-blind, randomised crossover trial","volume":"14","author":"Kefalopoulou","year":"2015","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2020.01.006_bib56","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S1474-4422(17)30160-6","article-title":"Anterior pallidal deep brain stimulation for Tourette's syndrome: a randomised, double-blind, controlled trial","volume":"16","author":"Welter","year":"2017","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2020.01.006_bib57","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.26094","article-title":"Tourette syndrome deep brain stimulation: a review and updated recommendations","volume":"30","author":"Schrock","year":"2015","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.ncl.2020.01.006_bib58","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jamaneurol.2017.4317","article-title":"Efficacy and safety of deep brain stimulation in Tourette syndrome: the International Tourette Syndrome Deep Brain Stimulation Public Database and Registry","volume":"75","author":"Martinez-Ramirez","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ncl.2020.01.006_bib59","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fnins.2016.00170","article-title":"The International Deep Brain Stimulation Registry and Database for Gilles de la Tourette syndrome: how does it work?","volume":"10","author":"Deeb","year":"2016","journal-title":"Front Neurosci"},{"key":"10.1016\/j.ncl.2020.01.006_bib60","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pnpbp.2016.02.003","article-title":"Treatment-refractory Tourette syndrome","volume":"70","author":"Kious","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"12","key":"10.1016\/j.ncl.2020.01.006_bib61","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/mds.21599","article-title":"Malignant Tourette syndrome","volume":"22","author":"Cheung","year":"2007","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.ncl.2020.01.006_bib62","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/ene.12207","article-title":"'It's a curse!': coprolalia in Tourette syndrome","volume":"20","author":"Eddy","year":"2013","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2020.01.006_bib63","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/mds.870110413","article-title":"Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome","volume":"11","author":"Scott","year":"1996","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.ncl.2020.01.006_bib64","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/mds.870110627","article-title":"Botulinum toxin for refractory vocal tics","volume":"11","author":"Salloway","year":"1996","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.ncl.2020.01.006_bib65","first-page":"143","article-title":"Tics status: a movement disorder emergency: observations","volume":"258","author":"Kovacs","year":"2011","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2020.01.006_bib66","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pediatrneurol.2016.05.008","article-title":"Severe neurological complications associated with Tourette syndrome","volume":"61","author":"Patterson","year":"2016","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ncl.2020.01.006_bib67","doi-asserted-by":"crossref","first-page":"450","DOI":"10.5334\/tohm.339","article-title":"Tic exacerbation in adults with tourette syndrome: a case series","volume":"7","author":"Schaefer","year":"2017","journal-title":"Tremor Other Hyperkinet Mov (N Y)"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861920300062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861920300062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:20:13Z","timestamp":1760005213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861920300062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0733861920300062"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2020.01.006","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical and Surgical Treatments of Tourette Syndrome","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2020.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}